Sunshine Biopharma Inc. Increase (Decrease) in Notes Payable, Related Parties
Sunshine Biopharma Inc. (SBFM) reported Increase (Decrease) in Notes Payable, Related Parties of $29.93 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInNotesPayableRelatedParties · last filed 2019-04-12
- Sunshine Biopharma Inc. increase (decrease) in notes payable, related parties for fiscal 2018 was $29.93K, a 1229.63% increase from fiscal 2017.
- Sunshine Biopharma Inc. increase (decrease) in notes payable, related parties for fiscal 2017 was $2.25K, a 96.64% decline from fiscal 2016.
- Sunshine Biopharma Inc. increase (decrease) in notes payable, related parties for fiscal 2016 was $67.03K.
- Sunshine Biopharma Inc. increase (decrease) in notes payable, related parties for fiscal 2015 was $0.00.
| Period end | Increase (Decrease) in Notes Payable, Related Parties 12 month |
|---|---|
| 2018-12-31 | $29.93K 10-K · filed 2019-04-12 |
| 2017-12-31 | $2.25K 10-K · filed 2019-04-12 |
| 2016-12-31 | $67.03K 10-K · filed 2018-04-02 |
| 2015-12-31 | $0.00 10-K · filed 2017-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |